edoxaban | CoronaCentral

edoxaban [Drug]

Wikidata: Q21011234

Published and Preprint Papers

Topics & Article Type(s)

Title

Clinical Trials, Therapeutics [Research]

Edoxaban and/or colchicine in outpatients with COVID-19: rationale and design of the CONVINCE trial.

Risk Factors, Therapeutics [Research]

Impact of atrial fibrillation and anticoagulation on the risk of death, thromboembolic disease and bleeding in patients with COVID-19: the ACO-VID Registry.

Clinical Reports [Research]

Platypnea-Orthodeoxia Syndrome in Coronavirus Disease 2019 Pneumonia: A Case Report and Literature Review.

Therapeutics [Research]

Edoxaban Versus Low-Molecular-Weight Heparin in Hospitalized COVID-19 Patients With Atrial Fibrillation.

Diagnostics [Research]

Development and validation of a novel Spectrofluorimetric method of oral anticoagulant Edoxaban via derivatization with 9-fluorenyl methyl chloroformate: green assessment of the method by Eco-Scale and ComplexGAPI.

Clinical Reports [Research]

Pulmonary embolism in a patient with eltrombopag-treated aplastic anaemia and paroxysmal nocturnal haemoglobinuria clone during COVID-19 pneumonia.

Clinical Reports [Research]

SARS-CoV-2 triggered seizure complicated by fatal subdural hematoma under edoxaban and clopidogrel.

Therapeutics [Research]

Impact of the COVID-19 pandemic on England's national prescriptions of oral vitamin K antagonist (VKA) and direct-acting oral anticoagulants (DOACs): An interrupted time series analysis (January 2019 - February 2021).

Diagnostics [Research]

Development and validation of capillary zone electrophoresis and high-performance liquid chromatography methods for the determination of oral anticoagulant edoxaban in pharmaceutical tablets.

Clinical Reports [Research]

A nitrous oxide abuser presenting with cerebral venous thrombosis: A case report.